Hypoglycemia, hyperglycemia, and gatifloxacin [4]

Annals of Internal Medicine

Volumn 141, Issue 12, 2004, Pages 969-

  Khovidhunkit, Weerapan ^a   Sunthornyothin, Sarat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; CEFACLOR; CEFOPERAZONE; CIPROFLOXACIN; DEXTROMETHORPHAN; FENOFIBRATE; GATIFLOXACIN; GLIBENCLAMIDE; GLUCOSE; HYDROCHLOROTHIAZIDE; INSULIN; ISOPHANE INSULIN; LEVOTHYROXINE; METOPROLOL; ROFECOXIB; SULBACTAM; TRIMETAZIDINE;

AGED; CASE REPORT; DIABETES MELLITUS; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; LETTER; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 11144257051     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-141-12-200412210-00022     Document Type: Letter

References (3)

1. Menzies DJ, Dorsainvil PA, Cunha BA, Johnson DH. Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. Am J Med. 2002;113:232-4. [PMID: 12208383]
2. Donaldson AR, Vandiver JR, Finch CK. Possible gatifloxacin-induced hyperglycemia. Ann Pharmacother. 2004;38:602-5. [PMID: 14982977]
3. Summary of Safety-Related Drug Labeling Changes Approved by FDA Center for Drug Evaluation. and Research (CDER). October 2002. Accessed at www.fda.gov/medwatch/SAFETY/2002/oct02.htm.